These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29422265)

  • 1. Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Taft C; Dellborg M
    Int J Cardiol; 2018 Apr; 257():46-49. PubMed ID: 29422265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Dellborg M
    Int J Cardiol; 2015 Sep; 195():293-9. PubMed ID: 26056962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
    Ntaios G; Papavasileiou V; Makaritsis K; Michel P
    Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale closure in post-CVA/TIA patients: psychological distress, quality of life and optimism.
    Cohen M; Daniela M; Lorber A
    Int J Clin Pract; 2010 Jan; 64(2):182-7. PubMed ID: 20089008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
    Davies A; Ekmejian A; Collins N; Bhagwandeen R
    Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of psychological symptoms in post-cryptogenic cerebral-vascular accident (CVA) and/or transient ischemic attack (TIA) patients who have undergone foramen ovale closure, and in post-CVA patients.
    Cohen M; Telman G; Mansoor D; Lorber A
    Arch Gerontol Geriatr; 2011; 52(3):e152-5. PubMed ID: 21075464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
    Mazzucco S; Li L; Binney L; Rothwell PM;
    Lancet Neurol; 2018 Jul; 17(7):609-617. PubMed ID: 29887162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P
    Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke.
    Kim M; Kim S; Moon J; Oh PC; Park YM; Shin DH; Lee YB; Lee JY; Hwang HY; Kang WC
    J Interv Cardiol; 2018 Jun; 31(3):368-374. PubMed ID: 28833599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
    Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.
    Lehmann R; Fichtlscherer S; Baldauf H; Schächinger V; Auch-Schwelck W; Zeiher AM; Teupe C
    J Cardiol; 2014 Aug; 64(2):113-6. PubMed ID: 24480741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
    Mazzucco S; Li L; Rothwell PM
    JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Del Val D; Côté M; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):219-224. PubMed ID: 31585849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective.
    Volpi JJ; Ridge JR; Nakum M; Rhodes JF; Søndergaard L; Kasner SE
    J Med Econ; 2019 Sep; 22(9):883-890. PubMed ID: 31025589
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous patent foramen ovale closure: the Paradoxical Cerebral Embolism Prevention Registry.
    Paiva L; Dinis P; Providência R; Costa M; Margalho S; Goncalves L
    Rev Port Cardiol; 2015 Mar; 34(3):151-7. PubMed ID: 25727752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.